The first Sorrento Therapeutics trade was made in Q1 2015.
Since then Ken Griffin bought shares 37 more times and sold shares on 31 occasions. The investor completely sold their stake between Q1 2023 and Q1 2023.
Avg closing price
Price range
Sold -200 Thousand shares
Q1 2023
Avg closing price
$0.65
Price range
$0.17
-
$1.19
Sold 87.1% shares (-1.35 Million shares)
Q4 2022
Avg closing price
$1.33
Price range
$0.74
-
$1.83
Increased shares by 133.1% (+885 Thousand shares)
Q3 2022
Avg closing price
$2.27
Price range
$1.51
-
$2.88
Sold 60.8% shares (-1.03 Million shares)
Q2 2022
Avg closing price
$1.73
Price range
$1.24
-
$2.33
Increased shares by 68.9% (+691 Thousand shares)
Q1 2022
Avg closing price
$3.12
Price range
$2.00
-
$4.90
Increased shares by 339.7% (+775 Thousand shares)
Q4 2021
Avg closing price
$6.21
Price range
$4.65
-
$7.23
Increased shares by 211.5% (+155 Thousand shares)
Q3 2021
Avg closing price
$8.48
Price range
$7.41
-
$10.99
Sold 87.3% shares (-503 Thousand shares)
Q2 2021
Avg closing price
$7.96
Price range
$6.35
-
$10.00
Increased shares by 943.1% (+521 Thousand shares)
Q1 2021
Avg closing price
$10.56
Price range
$7.03
-
$16.51
Sold 86.8% shares (-365 Thousand shares)
Q3 2020
Avg closing price
$9.15
Price range
$6.17
-
$18.82
New holding (+420 Thousand shares)
Q2 2020
Avg closing price
$3.83
Price range
$1.73
-
$6.76
Sold -299 Thousand shares
Q4 2019
Avg closing price
$2.38
Price range
$1.45
-
$4.17
Sold 17.4% shares (-62.7 Thousand shares)
Q3 2019
Avg closing price
$2.33
Price range
$2.05
-
$2.69
Increased shares by 750.8% (+319 Thousand shares)
Q2 2019
Avg closing price
$3.60
Price range
$2.67
-
$4.38
Sold 83.7% shares (-219 Thousand shares)
Q1 2019
Avg closing price
$2.62
Price range
$1.86
-
$5.94
Increased shares by 1818.7% (+247 Thousand shares)
Q4 2018
Avg closing price
$3.27
Price range
$2.01
-
$4.24
Sold 82.5% shares (-64.1 Thousand shares)
Q3 2018
Avg closing price
$5.54
Price range
$4.22
-
$7.50
Increased shares by 224.0% (+53.7 Thousand shares)
Q2 2018
Avg closing price
$6.80
Price range
$4.75
-
$8.00
Increased shares by 90.5% (+11.4 Thousand shares)
Q1 2018